A previously unrecognized bat virus has infected humans

Date:

Share this article:

Del denne artikel:

New research suggests that current disease surveillance systems may be overlooking animal-borne viruses that do not fit existing diagnostic frameworks.

Global disease surveillance is built to spot known threats. Tests are designed around familiar pathogens, case definitions follow past outbreaks, and warning systems often activate only when something looks recognisable.

That approach leaves a growing blind spot: infections that imitate known diseases but are caused by something else entirely.

Public health experts have warned for years that this diagnostic gap could allow new zoonotic viruses to circulate undetected.

A recent study adds weight to that concern, showing how easily human infections can slip past surveillance when they fall outside standard testing frameworks.

Also read: Fish reveal why diabetes medication can protect the kidneys

When tests look the wrong way

Researchers from Columbia University’s Mailman School of Public Health revisited patient samples collected through a Nipah virus surveillance program.

These were cases where symptoms strongly suggested Nipah, yet lab tests came back negative.

Using advanced sequencing tools that scan broadly for viral genetic material, scientists identified Pteropine orthoreovirus (PRV), a bat-borne virus rarely tested for in routine clinical settings.

In several patients, live virus was confirmed, indicating active infection rather than incidental exposure.

Also read: COVID symptoms are less obvious - Here’s what doctors say to watch for

The findings point to a structural issue in outbreak detection: surveillance programs may be too narrowly focused to detect unfamiliar spillover events.

Why Bangladesh matters

The cases were identified in Bangladesh, where human contact with bats is relatively common due to agricultural and food practices.

All patients had consumed raw date palm sap, a known interface between bats and humans.

While the setting is local, the implications are global. Similar gaps could exist anywhere surveillance is centered on a short list of expected pathogens.

Also read: Pregnancy and breastfeeding may shape women’s cognitive health decades later

A wider spillover problem

PRV joins a list of animal-origin viruses that initially caused human illness without immediate recognition, much like early cases of SARS or MERS.

Researchers say expanding diagnostic scope, not just geographic coverage, may be key to preventing the next global health crisis.

Kilde: ScienceDaily and CDC

Also read: This can happen to your body if you copy Donald Trump’s diet

Also read: Flu vaccination later in the winter can still make a difference

This article is made and published by Mie Hermansen, who may have used AI in the preparation.

Other articles

Can sauna sessions help reduce depression? Here’s what researchers found

Could raising your body temperature help ease depression? New clinical trials are exploring how deep heat therapy affects mood.

New COVID-19 variant spreads: Here are 14 symptoms you should know

A COVID-19 variant known as XFG is spreading across the UK, where both infection rates and hospital admissions...

A new herpes drug just got FDA approval for cases where nothing else works

After nearly three decades without a new way to fight the virus, one group of patients finally has another option.

Needles hurt less when you listen to this kind of music, study finds

Researchers tested four kinds of music on patients getting an IV, and only one type made a measurable difference.

Can sauna sessions help reduce depression? Here’s what researchers found

Could raising your body temperature help ease depression? New clinical trials are exploring how deep heat therapy affects mood.

New COVID-19 variant spreads: Here are 14 symptoms you should know

A COVID-19 variant known as XFG is spreading across the UK, where both infection rates and hospital admissions...

A new herpes drug just got FDA approval for cases where nothing else works

After nearly three decades without a new way to fight the virus, one group of patients finally has another option.